跳至主要内容
临床试验/NCT02311179
NCT02311179进行中(未招募)不适用

The Effect of Implant Coating With Hydroxyapatite Deposited Electrochemically (BoneMaster) on Migration and Clinical Outcome in Hip Arthroplasty With the Exceed Cup

University of Aarhus2 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
56
试验地点
2
主要终点
Radiographic: Migration of the acetabular component (mm, degree) with Model-Based RSA (m-RSA)

研究概览

简要总结

This study focuses on the effect of the hydroxyapatite coating with BoneMaster on the fixation of the hip prosthesis in primary hip alloplasty. A hemispheric joint cup of the type Exceed cup (Biomet) characterized by a porous surface of titanium plasma spray is used. The surface is coated with hydroxyapatite deposited electrochemically (BoneMaster) and will be compared with an identical cup without hydroxyapatite.

详细描述

This study focuses on the effect of the hydroxyapatite coating with BoneMaster on the fixation of the hip prosthesis in primary hip alloplasty. A hemispheric joint cup of the type Exceed cup (Biomet) characterized by a porous surface of titanium plasma spray is used. The surface is coated with hydroxyapatite deposited electrochemically (BoneMaster) and will be compared with an identical cup without hydroxyapatite. A 5-year radiologic analysis of migration will be carried out with the object of detecting prognostic evidence of prosthesis loosening. Migration is determined by Roentgen Stereo-photogrammetric Analysis (RSA) on stereoroentgenography. Simultaneously, the patients will be monitored by using the clinical outcome measure HOOS (Hip disability and osteoarthritis outcome score), OHS (Oxford Hip Score), EQ-5D (EuroQol), HHS (Harris Hip Score) on range of motion, VAS (Visual Analog Scale), postoperative complications and reoperation.

Hypothesis

We expect that the Exceed cup with hydroxyapatite deposited electrochemically (BoneMaster) is superior or equal compared to a similar cup without hydroxyapatite regarding

  • mechanical stability (RSA)
  • (clinical outcome)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptomatic radiographic osteoarthritis
  • Radiographically and clinically adequate bone quality with regard to a total hip prosthesis, including osteoporosis-Dexa-Scanning verification.
  • Age 55 to 75 years
  • Informed written consent

排除标准

  • Orthopaedic
  • Other disease of affected hip than primary coxarthrosis at time of inclusion 1.
  • Secondary osteoarthritis 1.1.
  • sequelae after acetabular fracture 1.1.
  • hip-near femoral fracture 1.1.
  • calve perthe 1.1.
  • dysplasia (severe) 1.1.
  • other 1.2 Atraumatic caput necrosis
  • Neuromuscular or vascular condition in one or the other lower extremity
  • Immobilization postoperative for long periods, for instance because of other serious diseases, alloplasties of the other lower-extremity joint, etc (decided by investigator)
  • Reoperation of affected hip because of 4.1 luxation (with closed or open reduction) 4.2 deep infection 4.3 fracture 4.4 aseptic loosening 4.5 other
  • Body Mass Index (BMI) at time of inclusion 81-84 5.1 ≥ 35 kg/m2 (grade 2+3 85, Obese Class I 81) 5.2 < 18,5 kg/m2 81-84
  • Insufficient RSA marker spread or rigidity Operative
  • Use of component other than Bimetric femoral stem (HA porous-coated without collar)
  • Unsuitable bone quality for uncemented hip alloplasty, evaluated preoperatively
  • Complications peroperatively on insertion of hip alloplasty that necessitate deviation for the described operative procedure (see section: "Operative procedure"), among others 9.1 per- and postoperative fracture 9.2 bone graft used peroperatively (treatment of bone defects, cysts, etc.) 9.3 screw fixation of the acetabulum 9.4 gluteal detachment or extensive femoral exposure 9.5 trochanter osteotomy 9.6 Under-reaming 1-2 mm (cup size is one mm larger than the reamer, i.e. reaming 51 mm, cup 52 mm) 9.7 Other Radiographic
  • Cup placement 10.1 Cup inclination in AP (anteroposterior) plan >56 degrees and <35 degrees as evaluated on roentgenogram Medical
  • Osteoporosis 11.
  • previously diagnosed 11.
  • project-related preoperative DEXA (dual energy x-ray absorptiometry ) scan Patients with osteoporosis on the scan (T-score < -2.5) are excluded from the study with referral to medical osteoporosis treatment. Patients with osteopenia (T-score < -1) are included in the project with referral to osteoporosis prophylactic treatment. Patients with osteopenia at project inclusion are DEXA re-scanned at the 2 year follow up.
  • Arthritis 12.
  • rheumatoid arthritis 12.
  • psoriasis arthritis 12.
  • other arthritides
  • Metabolic bone disease 13.
  • hyperparathyroidism 13.
  • Paget bone disease 13.
  • renal osteodystrophy 13.
  • Reduced kidney function thereby influencing bone metabolism
  • Previous treatment of skeleton with radiation therapy
  • Cancer Pharmaceuticals
  • Pharmaceuticals that effect calcium-phosphorus metabolism and bone density 87-98, either through intermittent administration or as a constant dose 17.
  • glucocorticoids (systemic) beyond short-term treatment (<5 days) 17.
  • immunosuppression/modulation (cyclosporine, methotrexate, etc.) Compliance related
  • Absent patient compliance with treatment and follow-up investigations
  • Abuse that the investigator feels would weaken compliance 19.
  • alcohol abuse 19.
  • medication abuse
  • Psychological instability (including patient in treatment lithium/antidepressants/neuroleptics/ antipsychotic drugs) which the investigator feels would weaken compliance

结局指标

主要结局

Radiographic: Migration of the acetabular component (mm, degree) with Model-Based RSA (m-RSA)

时间窗: End of study (up to 5 years)

次要结局

  • Postoperative complications (up to 5 years)(End of study)
  • HOOS (Hip disability and osteoarthritis outcome score)(End of study (up to 5 years))
  • Reoperation of affected hips(End of study (up to 5 years))
  • OHS (Oxford Hip Score)(End of study (up to 5 years))
  • HHS (Harris Hip Score) on Range Of Motion (ROM)(End of study (up to 5 years))
  • VAS (Visual Analog Scale) at rest and load(End of study (up to 5 years))
  • EQ-5D (EuroQol)(End of study (up to 5 years))
  • Radiologic osteolysis(End of study (up to 5 years))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验